Xianying Liao

Featured in: Favicon

Articles

Functionalizing Sgc8‐Paclitaxel Conjugates with F‐Base Modifications: Targeted Drug Delivery with Optimized Cardiac Safety

May 23, 2024 | onlinelibrary.wiley.com | Yue Ma |Xianying Liao |Guiping Lu |Xinyuan Chen

Conflict of interests The authors declare no conflict of interest. References 1 1a, , , , , , , , , , , , , , , , , , , , , , Nat. Commun. 2020, 11, 4965.. 2, , , Nat. Rev. Clin. Oncol. 2018, 16, 27–44. 3 3a, Nat. Rev. Cardiol. 2020, 17, 474–502.. 4, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eur. Heart J. 2022, 43, 4229–4361. 5 5a, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eur. Heart J.
Functionalizing Sgc8‐Paclitaxel Conjugates with F‐Base Modifications: Targeted Drug Delivery with Optimized Cardiac Safety

May 23, 2024 | chemistry-europe.onlinelibrary.wiley.com | Yue Ma |Guiping Lu |Xinyuan Chen |Xianying Liao

Recent advancements in cancer treatment have improved patient prognoses, but chemotherapy-induced cardiotoxicity remains a prevalent concern. This study explores the potential of F-base-modified aptamers for targeted drug delivery, focusing on their impact on cardiotoxicity.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.